Latest Episodes

Biotech M&A Booms, But Have We Reached A Tipping Point?

Gregory Renza, M.D., Senior Biotechnology Analyst, delves into the driving forces behind the recent surge of...

Read Time Read (4m) | View
Listen Time Listen (16m) | Apple Spotify

When to Call it Quits: VCs Making Tough Decisions in a Tough Market

RBC’s Noël Brown, Head of US Biotechnology Investment Banking, recently held an Endpoints roundtable with...

Read Time Read (4m) | View
Listen Time Listen (32m) | Apple Spotify

The Power and Potential of Genetic Medicine

Genetic medicine is poised to unlock more value for patients and investors. RBC’s biotechnology analyst Luca...

Read Time Read (3m) | View
Listen Time Listen (17m) | Apple Spotify

The Competitive Landscape of Gene Therapy and Immuno-oncology

The road is paved for gene therapy and immuno-oncology treatment innovation in 2023 as emerging clinical...

Read Time Read (5m) | View

The Hidden Revolution Set to Turn US Healthcare on its Head

In this episode of Pathfinders, RBC’s Healthcare Technology Analyst Sean Dodge discusses the value-based...

Read Time Read (3m) | View
Listen Time Listen (19m) | Apple Spotify

The Big Picture for Biotech

In this latest episode, our head of biotech research Brian Abrahams shares a big picture analysis of the...

Read Time Read (3m) | View
Listen Time Listen (21m) | Apple Spotify

Pathfinders in Biopharma Podcast

Our podcast series explores the fast-moving world of biopharma and what the road ahead looks like for companies and investors in the sector.

Subscribe Now

More Healthcare insights

From biotech breakthroughs to digital transformation, our global healthcare specialists dive deep into the latest trends, innovations, and emerging opportunities.

Stay Informed

Get the latest insights from RBC Capital Markets delivered to your inbox.